American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top ...

Value investing has long been a preferred strategy among investors, largely influenced by Warren Buffett, who continues to ...

It’s important to note that Zervos praised Cuggino’s diversified portfolio approach, particularly his use of hedges and fixed ...

Approximately 163 employees will be impacted by the pending closure of Merck’s Cherokee plant with layoffs set to begin in ...

The Prayoga Institute of Education Research, in partnership with Merck, extends its Kriya initiative to 45 government schools across Karnataka, enhancing science education for over 7,000 students.

White House reports declining inflation and job market gains under Trump's policies, with added border security success.

The current Wall Street sell-off has wiped out billions in market value, hammering tech giants, banks, and airlines while ...

Dividend-paying stocks are a traditional defensive play, while healthcare faces fewer trade and economic headwinds than most ...

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...

The Breez 2 mL micro-bioreactor platform is a fully automated, functionally closed, and continuous perfusion cell culture ...